Lantern Pharma Inc.
LTRN
$3.75
-$0.18-4.58%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.05M | 33.26M | 38.36M | 41.30M | 44.93M |
| Total Receivables | -- | -- | -- | 860.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.12M | 1.09M | 736.00K | 433.00K | 1.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 748.00K | 935.00K | 377.00K | 745.70K | 797.00K |
| Total Current Assets | 29.92M | 35.29M | 39.47M | 43.34M | 47.43M |
|
|
|||||
| Total Current Assets | 29.92M | 35.29M | 39.47M | 43.34M | 47.43M |
| Net Property, Plant & Equipment | 335.60K | 263.30K | 237.50K | 280.40K | 319.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.70K | 32.00K | 25.90K | 25.90K | 25.90K |
| Total Assets | 30.29M | 35.59M | 39.73M | 43.65M | 47.77M |
|
|
|||||
| Total Accounts Payable | 2.55M | 2.42M | 1.61M | 942.20K | 1.57M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 197.30K | 164.00K | 178.00K | 173.00K | 168.00K |
| Total Finance Division Other Current Liabilities | 855.00K | 2.02M | 2.16M | 1.56M | 516.00K |
| Total Other Current Liabilities | 855.00K | 2.02M | 2.16M | 1.56M | 516.00K |
| Total Current Liabilities | 3.60M | 4.60M | 3.95M | 2.68M | 2.25M |
|
|
|||||
| Total Current Liabilities | 3.60M | 4.60M | 3.95M | 2.68M | 2.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 94.00K | 54.70K | 15.60K | 61.50K | 106.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.70M | 4.66M | 3.97M | 2.74M | 2.36M |
|
|
|||||
| Common Stock & APIC | 96.77M | 96.58M | 96.45M | 96.26M | 96.61M |
| Retained Earnings | -70.15M | -65.64M | -60.69M | -55.24M | -51.06M |
| Treasury Stock & Other | -25.30K | -6.60K | 1.90K | -107.50K | -138.80K |
| Total Common Equity | 26.60M | 30.93M | 35.77M | 40.91M | 45.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.60M | 30.93M | 35.77M | 40.91M | 45.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.60M | 30.93M | 35.77M | 40.91M | 45.41M |
|
|
|||||
